Literature DB >> 2820820

Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain.

D A Brase1, Y H Han, W L Dewey.   

Abstract

The effects of glucose and diabetes on the high-affinity lofentanil-displaceable opiate-receptor binding in mouse brain membranes were studied to determine if the attenuation of opiate actions by hyperglycemia previously observed in our laboratory was due to a modification of receptor affinity or number. With membranes from normal ICR mice, glucose (100-400 mg/dl) caused small but significant concentration-dependent decreases in receptor affinities for [3H]naloxone and [3H]dihydromorphine, both in the absence and presence of 20 mM NaCl, without changing the maximum number of binding sites. Fructose and the nonmetabolizable sugar 3-O-methylglucose had intermediate effects on naloxone affinity in the presence of NaCl that were not significantly different from control or from the effect of glucose. Similar results were obtained with brain membranes from streptozocin-induced diabetic mice. The binding affinity for [3H]naloxone in the presence of NaCl was not affected by the induction of diabetes in ICR mice via streptozocin or in spontaneously diabetic (db/db) C57BL/KsJ mice compared with their nondiabetic (m+/m+) littermates. These results indicate that the previously observed attenuation of opiate effects by glucose may be partly due to a glucose-induced decrease in opiate-receptor affinity. However, the much greater attenuation of morphine by fructose in vivo cannot be explained by this mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820820     DOI: 10.2337/diab.36.10.1173

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections.

Authors:  M E Ragozzino; S N Pal; K Unick; M R Stefani; P E Gold
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

2.  Septal co-infusions of glucose with the benzodiazepine agonist chlordiazepoxide impair memory, but co-infusions of glucose with the opiate morphine do not.

Authors:  Desiree L Krebs-Kraft; Marise B Parent
Journal:  Physiol Behav       Date:  2009-12-22

3.  Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose.

Authors:  M E Ragozzino; K E Unick; P E Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

4.  The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice.

Authors:  J Kamei; N Kawashima; Y Iwamoto; T Suzuki; H Nagase; M Misawa; Y Kasuya
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Opiate-mediated inhibition of calcium signaling is decreased in dorsal root ganglion neurons from the diabetic BB/W rat.

Authors:  K E Hall; A A Sima; J W Wiley
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

6.  Naloxone modulates the behavioral effects of cholinergic agonists and antagonists.

Authors:  D L Walker; T McGlynn; C Grey; M Ragozzino; P E Gold
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Reduction in ATP-sensitive potassium channel-mediated antinociception in diabetic mice.

Authors:  J Kamei; N Kawashima; M Narita; T Suzuki; M Misawa; Y Kasuya
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.